These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 16773211)
1. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment. Zhou Y; Inaba S; Liu J Int J Oncol; 2006 Jul; 29(1):289-95. PubMed ID: 16773211 [TBL] [Abstract][Full Text] [Related]
2. Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Singh VK; Zhou Y; Marsh JA; Uversky VN; Forman-Kay JD; Liu J; Jia Z Cancer Res; 2007 Jan; 67(2):626-33. PubMed ID: 17234772 [TBL] [Abstract][Full Text] [Related]
3. Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Inaba S; Li C; Shi YE; Song DQ; Jiang JD; Liu J Breast Cancer Res Treat; 2005 Nov; 94(1):25-35. PubMed ID: 16142440 [TBL] [Abstract][Full Text] [Related]
4. [Influence of SNCG transfection on the effectiveness of anti-tumor drugs in PC-3 cell lines]. Chen JL; Wang B; Zhang LR; He BS; Pan YQ; Zeng QD; Jiang HX; Wang SK Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1077-82. PubMed ID: 19157226 [TBL] [Abstract][Full Text] [Related]
5. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081 [TBL] [Abstract][Full Text] [Related]
6. [Overexpression of synuclein-gamma confers resistance to antimicrotubule drugs against human hepatoma cells]. Cheng SX; Zhang S; Zhang H; Song DQ; Wang YP; Li YH; You XF; Wang YM; Jiang JD Yao Xue Xue Bao; 2010 Jun; 45(6):724-9. PubMed ID: 20939180 [TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B. Liu H; Zhou Y; Boggs SE; Belinsky SA; Liu J Oncogene; 2007 Aug; 26(40):5900-10. PubMed ID: 17369845 [TBL] [Abstract][Full Text] [Related]
8. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance. Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897 [TBL] [Abstract][Full Text] [Related]
9. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration. Zhao W; Liu H; Liu W; Wu Y; Chen W; Jiang B; Zhou Y; Xue R; Luo C; Wang L; Jiang JD; Liu J Int J Oncol; 2006 May; 28(5):1081-8. PubMed ID: 16596223 [TBL] [Abstract][Full Text] [Related]
10. Stage-specific expression of breast cancer-specific gene gamma-synuclein. Wu K; Weng Z; Tao Q; Lin G; Wu X; Qian H; Zhang Y; Ding X; Jiang Y; Shi YE Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):920-5. PubMed ID: 14504205 [TBL] [Abstract][Full Text] [Related]
11. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer. Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827 [TBL] [Abstract][Full Text] [Related]
12. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927 [TBL] [Abstract][Full Text] [Related]
13. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines. Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282 [TBL] [Abstract][Full Text] [Related]
14. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells. Pratt MA; Niu MY; Renart LI Apoptosis; 2006 Apr; 11(4):589-605. PubMed ID: 16528475 [TBL] [Abstract][Full Text] [Related]
15. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Liu H; Liu W; Wu Y; Zhou Y; Xue R; Luo C; Wang L; Zhao W; Jiang JD; Liu J Cancer Res; 2005 Sep; 65(17):7635-43. PubMed ID: 16140929 [TBL] [Abstract][Full Text] [Related]
16. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response. Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644 [TBL] [Abstract][Full Text] [Related]
17. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464 [TBL] [Abstract][Full Text] [Related]
18. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity. Sun X; Li D; Yang Y; Ren Y; Li J; Wang Z; Dong B; Liu M; Zhou J J Pathol; 2012 Mar; 226(4):666-73. PubMed ID: 21989536 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells. Luker KE; Pica CM; Schreiber RD; Piwnica-Worms D Cancer Res; 2001 Sep; 61(17):6540-7. PubMed ID: 11522652 [TBL] [Abstract][Full Text] [Related]
20. High Raf-1 kinase activity protects human tumor cells against paclitaxel-induced cytotoxicity. Rasouli-Nia A; Liu D; Perdue S; Britten RA Clin Cancer Res; 1998 May; 4(5):1111-6. PubMed ID: 9607567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]